UNK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.429640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.844000E-01
Normal-vs-Stage2
1.623970E-02
Normal-vs-Stage3
1.196160E-01
Normal-vs-Stage4
1.478590E-01
Stage1-vs-Stage2
4.660200E-01
Stage1-vs-Stage3
3.075200E-01
Stage1-vs-Stage4
3.757600E-01
Stage2-vs-Stage3
3.573600E-01
Stage2-vs-Stage4
6.209600E-01
Stage3-vs-Stage4
6.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.797000E-01
Normal-vs-AfricanAmerican
3.003400E-01
Normal-vs-Asian
4.878400E-02
Caucasian-vs-AfricanAmerican
1.414020E-01
Caucasian-vs-Asian
2.338600E-01
AfricanAmerican-vs-Asian
9.022400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.928440E-01
Normal-vs-Female
9.683900E-02
Male-vs-Female
9.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.562800E-01
Normal-vs-Age(41-60Yrs)
1.550010E-01
Normal-vs-Age(61-80Yrs)
1.348030E-01
Normal-vs-Age(81-100Yrs)
2.967400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.566000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.099600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.710800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.590200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.137600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.616800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.655600E-02
Normal-vs-Daily Drinker
2.535400E-01
Normal-vs-Weekly Drinker
5.894300E-02
Normal-vs-Occasional Drinker
2.788400E-01
Normal-vs-Social Drinker
2.346600E-01
Non Drinker-vs-Daily Drinker
9.307000E-01
Non Drinker-vs-Weekly Drinker
9.647200E-01
Non Drinker-vs-Occasional Drinker
4.199400E-01
Non Drinker-vs-Social Drinker
2.481400E-01
Daily Drinker-vs-Weekly Drinker
9.050000E-01
Daily Drinker-vs-Occasional Drinker
6.089000E-01
Daily Drinker-vs-Social Drinker
4.282000E-01
Weekly Drinker-vs-Occasional Drinker
4.623200E-01
Weekly Drinker-vs-Social Drinker
2.412800E-01
Occasional Drinker-vs-Social Drinker
8.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.635600E-01
Normal-vs-Grade 2
8.215800E-01
Normal-vs-Grade 3
8.050800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.365600E-02
Grade 1-vs-Grade 3
5.200400E-02
Grade 1-vs-Grade 4
4.635600E-01
Grade 2-vs-Grade 3
7.408400E-01
Grade 2-vs-Grade 4
8.215800E-01
Grade 3-vs-Grade 4
8.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.758200E-02
Normal-vs-NonDiabetic
2.424400E-01
Diabetic-vs-NonDiabetic
3.666800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.875800E-01
Normal-vs-NoPancreatitis
1.822390E-01
Pancreatitis-vs-NoPancreatitis
1.376410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.868600E-01
Normal-vs-N1
3.159600E-01
N0-vs-N1
1.687590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.856400E-01
Normal-vs-TP53-NonMutant
6.098400E-01
TP53-Mutant-vs-TP53-NonMutant
1.378970E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
